T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEVA
2701
Aeva Technologies
AEVA
$1.56B
| $108K | ﹤0.01% |
28,354
+11,680
| +70% | +$37.3K |
|
2702
Ardagh Metal Packaging
AMBP
$3.16B
| $108K | ﹤0.01% |
27,959
+3,412
| +14% | +$11.9K |
|
2703
Fulcrum Therapeutics
FULC
$283M
| $108K | ﹤0.01% |
15,900
| – | – |
|
2704
Ocugen
OCGN
$458M
| $108K | ﹤0.01% |
187,100
+93,000
| +99% | +$37.3K |
|
2705
Omeros
OMER
$1.26B
| $108K | ﹤0.01% |
32,933
+1,705
| +5% | +$3.6K |
|
|
SUP
2706
DELISTED
Superior Industries International
SUP
| $108K | ﹤0.01% |
33,700
| – | – |
|
2707
iQIYI
IQ
$1.31B
| $107K | ﹤0.01% |
21,820
+9,120
| +72% | +$43.1K |
|
|
ESPR
2708
DELISTED
Esperion Therapeutics
ESPR
| $106K | ﹤0.01% |
35,400
| – | – |
|
2709
Mammoth Energy Services
TUSK
$154M
| $105K | ﹤0.01% |
23,326
+574
| +3% | +$2.54K |
|
|
CTLP
2710
DELISTED
Cantaloupe
CTLP
| $104K | ﹤0.01% |
13,912
+828
| +6% | +$5.72K |
|
2711
Stereotaxis
STXS
$137M
| $103K | ﹤0.01% |
58,400
| – | – |
|
|
VIA
2712
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $103K | ﹤0.01% |
10,880
| – | – |
|
2713
Lineage Cell Therapeutics
LCTX
$268M
| $100K | ﹤0.01% |
90,896
+5,560
| +7% | +$6.09K |
|
|
KYNB
2714
Kyntra Bio
KYNB
$28.5M
| $99K | ﹤0.01% |
4,456
+1,628
| +58% | +$24.6K |
|
2715
MaxCyte
MXCT
$149M
| $99K | ﹤0.01% |
20,879
+2,082
| +11% | +$8.11K |
|
2716
Telos
TLS
$344M
| $99K | ﹤0.01% |
27,006
| – | – |
|
2717
Bit Digital
BTBT
$520M
| $97K | ﹤0.01% |
22,888
+7,419
| +48% | +$19.4K |
|
2718
GoodRx Holdings
GDRX
$1.27B
| $96K | ﹤0.01% |
14,300
| – | – |
|
2719
NextDecade
NEXT
$1.8B
| $96K | ﹤0.01% |
+20,053
| New | +$93.4K |
|
2720
Citizens
CIA
$198M
| $94K | ﹤0.01% |
34,900
| – | – |
|
2721
Clarus
CLAR
$145M
| $94K | ﹤0.01% |
13,505
+917
| +7% | +$5.38K |
|
2722
Kartoon Studios
TOON
$38.2M
| $93K | ﹤0.01% |
66,240
| – | – |
|
2723
TeraWulf
WULF
$8.14B
| $93K | ﹤0.01% |
38,632
+9,090
| +31% | +$12.4K |
|
|
FARM
2724
DELISTED
Farmer Brothers
FARM
| $91K | ﹤0.01% |
29,600
| – | – |
|
2725
FTAI Infrastructure
FIP
$551M
| $91K | ﹤0.01% |
23,239
+1,519
| +7% | +$5.32K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.